{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:33:57Z","timestamp":1782952437336,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To analyze outcomes of pulsatile administration of gonadotropin-releasing hormone (GnRH) in infertile women diagnosed with functional hypothalamic amenorrhea (FHA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A single-center retrospective cohort study was conducted from 1996 to 2020. Sixty-six patients with the diagnosis FHA that underwent therapy using the pulsatile GnRH pump for conception were included and analyzed. The primary outcome was the live birth rate (LBR). Secondary outcomes were the number of dominant follicles, ovulation rate, biochemical pregnancy rate (BPR), clinical pregnancy rate (CPR), miscarriage rate, and multiple pregnancy rate. A matched control group was selected to compare the birth weight of newborn children.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During the study period, 66 patients with FHA underwent 82 treatments (14 of 66 patients had more than one treatment) and a total of 212 cycles (ovulation induction attempts) using pulsatile GnRH. The LBR per treatment was 65.9%. The ovulation rate per cycle was 96%, and monofollicular ovulation was observed in 75% of cycles. The BPR per treatment was 80.5%, and the cumulative CPR per treatment was 74.4%. The miscarriage rate was 11.5%. One dizygotic twin pregnancy was observed (1.6%). Average newborn birth weight (NBW) from patients with FHA was comparable to the control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion(s)<\/jats:title>\n                <jats:p>In patients with FHA, excellent pregnancy rates were achieved using the subcutaneous GnRH pump. The high cumulative LBR with normal NBW as well as low rates of multiple gestation indicate that the pulsatile GnRH pump represents a safer and more physiologic alternative to ovulation induction with injectable gonadotropins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration\n<\/jats:title>\n                <jats:p>Ethics Committee Northwest and Central Switzerland (Ethikkommission Nordwest- und Zentralschweiz - EKNZ) - Project-ID 2020-01612.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10815-022-02656-0","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T05:09:52Z","timestamp":1668488992000},"page":"2729-2736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Use of pulsatile gonadotropin-releasing hormone (GnRH) in patients with functional hypothalamic amenorrhea (FHA) results in monofollicular ovulation and high cumulative live birth rates: a 25-year cohort"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-1783","authenticated-orcid":false,"given":"Philipp","family":"Quaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"De Geyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"2656_CR1","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s40618-014-0169-3","volume":"37","author":"B Meczekalski","year":"2014","unstructured":"Meczekalski B, Katulski K, Czyzyk A, Podfigurna-Stopa A, MacIejewska-Jeske M. Functional hypothalamic amenorrhea and its influence on women\u2019s health. J Endocrinol Invest. 2014;37:1049\u201356.","journal-title":"J Endocrinol Invest"},{"key":"2656_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMcp0912024","volume":"363","author":"CM Gordon","year":"2010","unstructured":"Gordon CM. Functional Hypothalamic Amenorrhea. N Engl J Med. 2010;363:365\u201371.","journal-title":"N Engl J Med"},{"key":"2656_CR3","doi-asserted-by":"crossref","unstructured":"Quaas AM, Legro RS. Pharmacology of medications used for ovarian stimulation. Best Pract Res Clin Endocrinol Metab. 2019;21\u201333.","DOI":"10.1016\/j.beem.2018.10.002"},{"key":"2656_CR4","doi-asserted-by":"crossref","unstructured":"Harlow SD. Menstruation and Menstrual Disorders. Women Heal. 2000;99\u2013113.","DOI":"10.1016\/B978-012288145-9\/50012-7"},{"key":"2656_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa0911064","volume":"364","author":"LM Caronia","year":"2011","unstructured":"Caronia LM, Martin C, Welt CK, Sykiotis GP, Quinton R, Thambundit A, et al. A Genetic Basis for Functional Hypothalamic Amenorrhea. N Engl J Med. 2011;364:215\u201325.","journal-title":"N Engl J Med"},{"key":"2656_CR6","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40519-020-00893-9","volume":"26","author":"I Barbosa-Magalhaes","year":"2021","unstructured":"Barbosa-Magalhaes I, Corcos M, Galey J, Perdigao-Cotta S, Papastathi C, de Crecy M, et al. Prevalence of lifetime eating disorders in infertile women seeking pregnancy with pulsatile gonadotropin-releasing hormone therapy. Eat Weight Disord. 2021;26:709\u201315.","journal-title":"Eat Weight Disord"},{"key":"2656_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/01.AOG.0000148265.90984.c3","volume":"105","author":"S Kouba","year":"2005","unstructured":"Kouba S, H\u00e4llstr\u00f6m T, Lindholm C, Hirschberg AL. Pregnancy and neonatal outcomes in women with eating disorders. Obstet Gynecol. 2005;105:255\u201360.","journal-title":"Obstet Gynecol"},{"key":"2656_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1176\/appi.ajp.158.9.1461","volume":"158","author":"DL Franko","year":"2001","unstructured":"Franko DL, Blais MA, Becker AE, Delinsky SS, Greenwood DN, Flores AT, et al. Pregnancy complications and neonatal outcomes in women with eating disorders. Am J Psychiatry. 2001;158:1461\u20136.","journal-title":"Am J Psychiatry"},{"key":"2656_CR9","first-page":"615","volume":"31","author":"C Arnold","year":"2019","unstructured":"Arnold C, Johnson H, Mahon C, Agius M. The effects of eating disorders in pregnancy on mother and baby: a review. Psychiatr Danub. 2019;31:615\u20138.","journal-title":"Psychiatr Danub"},{"key":"2656_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fped.2020.00587","volume":"8","author":"G Sebastiani","year":"2020","unstructured":"Sebastiani G, Andreu-Fern\u00e1ndez V, Herranz Barbero A, Aldecoa-Bilbao V, Miracle X, Meler Barrabes E, et al. Eating disorders during gestation: implications for mother\u2019s health, fetal outcomes, and epigenetic changes. Front Pediatr. 2020;8:1\u201337.","journal-title":"Front Pediatr"},{"key":"2656_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00006254-197103000-00015","volume":"26","author":"RE Frisch","year":"1971","unstructured":"Frisch RE, Revelle R. Height and weight at menarche and a hypothesis of critical body weights and adolescent events. Obstet Gynecol Surv. 1971;26:254\u20135.","journal-title":"Obstet Gynecol Surv"},{"key":"2656_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/humupd\/dmaa032","volume":"27","author":"J Pape","year":"2021","unstructured":"Pape J, Herbison AE, Leeners B. Recovery of menses after functional hypothalamic amenorrhoea: if, when and why. Hum Reprod Update. 2021;27:130\u201353.","journal-title":"Hum Reprod Update"},{"key":"2656_CR13","first-page":"302","volume":"4","author":"TG Nazem","year":"2012","unstructured":"Nazem TG, Ackerman KE. The female athlete triad. Sports. Health. 2012;4:302\u201311.","journal-title":"Health"},{"key":"2656_CR14","doi-asserted-by":"crossref","unstructured":"Gibson MES, Fleming N, Zuijdwijk C, Dumont T. Where have the periods gone? the evaluation and management of functional hypothalamic amenorrhea. J Clin Res Pediatr Endocrinol. 2020;18\u201327.","DOI":"10.4274\/jcrpe.galenos.2019.2019.S0178"},{"key":"2656_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","volume":"43","author":"AV Schally","year":"1971","unstructured":"Schally AV, Arimura A, Baba Y, Nair RMG, Matsuo H, Redding TW, et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun. 1971;43:393\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"2656_CR16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/endo-87-5-850","volume":"87","author":"DJ Dierschke","year":"1970","unstructured":"Dierschke DJ, Bhattacharya AN, Atkinson LE, Knobil E. Circhoral oscillations of plasma LH levels in the ovariectomized rhesus monkey. Endocrinology. 1970;87:850\u20133.","journal-title":"Endocrinology"},{"key":"2656_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1210\/endo-96-5-1099","volume":"96","author":"WR Butler","year":"1975","unstructured":"Butler WR, Krey LC, Lu KH, Peckham WD, Knobil E. Surgical disconnection of the medial basal hypothalamus and pituitary function in the rhesus monkey. IV. Prolactin secretion. Endocrinology. 1975;96:1099\u2013105.","journal-title":"Endocrinology"},{"key":"2656_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/oxfordjournals.humrep.a136730","volume":"3","author":"E Knobil","year":"1988","unstructured":"Knobil E. The neuroendocrine control of ovulation. Hum Reprod. 1988;3:469\u201372.","journal-title":"Hum Reprod"},{"key":"2656_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1126\/science.100883","volume":"202","author":"PE Belchetz","year":"1978","unstructured":"Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science. 1978;202:631\u20133.","journal-title":"Science"},{"key":"2656_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1210\/jcem-51-5-1214","volume":"51","author":"G Leyendecker","year":"1980","unstructured":"Leyendecker G, Wildt L, Hansmann M. Pregnancies following chronic intermittent (Pulsatile) administration of gn-rh by means of a portable pump (\u201czyklomat\u201d) - a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab. 1980;51:1214\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"2656_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/jrf.0.0690397","volume":"69","author":"G Leyendecker","year":"1983","unstructured":"Leyendecker G, Wildt L. Induction of ovulation with chronic intermittent (pulsatile) administration of Gn-RH in women with hypothalamic amenorrhoea. J Reprod Fertil. 1983;69:397\u2013409.","journal-title":"J Reprod Fertil"},{"key":"2656_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/humrep\/8.suppl_2.184","volume":"8","author":"G Leyendecker","year":"1993","unstructured":"Leyendecker G, Waibel-Treber S, Wudt L. Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea. Hum Reprod. 1993;8:184\u20138.","journal-title":"Hum Reprod"},{"key":"2656_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.fertnstert.2017.12.028","volume":"109","author":"A Tranoulis","year":"2018","unstructured":"Tranoulis A, Laios A, Pampanos A, Yannoukakos D, Loutradis D, Michala L. Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and functional hypothalamic amenorrhea: a systematic review of the literature and a meta-analysis. Fertil Steril. 2018;109:708\u201319.","journal-title":"Fertil Steril"},{"key":"2656_CR24","first-page":"1215","volume":"79","author":"M Filicori","year":"1994","unstructured":"Filicori M, Flamigni C, Dellai P, Cognigni G, Michelacci L, Arnone R, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab. 1994;79:1215\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"2656_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/jcem-72-5-965","volume":"72","author":"M Filicori","year":"1991","unstructured":"Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, et al. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. J Clin Endocrinol Metab. 1991;72:965\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"2656_CR26","first-page":"125","volume":"77","author":"KA Martin","year":"1993","unstructured":"Martin KA, Hall JE, Adams JM, Crowley WF. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993;77:125\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2656_CR27","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1530\/REP-17-0697","volume":"156","author":"DM White","year":"2018","unstructured":"White DM, Hardy K, Lovelock S, Franks S. Low-dose gonadotropin induction of ovulation in anovulatory women: still needed in the age of IVF. Reproduction. 2018;156:F1-10.","journal-title":"Reproduction"},{"key":"2656_CR28","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/09513590.2016.1191462","volume":"32","author":"A Dumont","year":"2016","unstructured":"Dumont A, Dewailly D, Plouvier P, Catteau-Jonard S, Robin G. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Gynecol Endocrinol. 2016;32:999\u20131004.","journal-title":"Gynecol Endocrinol"},{"key":"2656_CR29","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/humrep\/12.9.1939","volume":"12","author":"N Tadokoro","year":"1997","unstructured":"Tadokoro N, Vollenhoven B, Clark S, Baker G, Kovacs G, Burger H, et al. Cumulative pregnancy rates in couples with anovulatory infertility compared with unexplained infertility in an ovulation induction programme. Hum Reprod. 1997;12:1939\u201344.","journal-title":"Hum Reprod"},{"key":"2656_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm11080814","volume":"11","author":"JL Keeler","year":"2021","unstructured":"Keeler JL, Patsalos O, Chung R, Schmidt U, Breen G, Treasure J, et al. Reduced mip-1\u03b2 as a trait marker and reduced il-7 and il-12 as state markers of anorexia nervosa. J Pers Med. 2021;11:1\u201318.","journal-title":"J Pers Med"},{"key":"2656_CR31","doi-asserted-by":"crossref","unstructured":"Patsalos O, Dalton B, Kyprianou C, Firth J, Shivappa N, H\u00e9bert JR, et al. Nutrient Intake and dietary inflammatory potential in current and recovered anorexia nervosa. Nutrients. 2021;13.","DOI":"10.3390\/nu13124400"},{"key":"2656_CR32","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1017\/S1368980013002115","volume":"17","author":"N Shivappa","year":"2014","unstructured":"Shivappa N, Steck SE, Hurley TG, Hussey JR, H\u00e9bert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17:1689\u201396.","journal-title":"Public Health Nutr"},{"key":"2656_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/microorganisms7090338","volume":"7","author":"P Prochazkova","year":"2019","unstructured":"Prochazkova P, Roubalova R, Dvorak J, Tlaskalova-Hogenova H, Cermakova M, Tomasova P, et al. Microbiota, Microbial Metabolites, and Barrier Function in A Patient with Anorexia Nervosa after Fecal Microbiota Transplantation. Microorganisms. 2019;7:338.","journal-title":"Microorganisms"},{"key":"2656_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1902771","volume":"13","author":"P Prochazkova","year":"2021","unstructured":"Prochazkova P, Roubalova R, Dvorak J, Kreisinger J, Hill M, Tlaskalova-Hogenova H, et al. The intestinal microbiota and metabolites in patients with anorexia nervosa. Gut Microbes. 2021;13:1\u201325.","journal-title":"Gut Microbes"},{"key":"2656_CR35","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/bmj.298.6676.809","volume":"298","author":"R Homburg","year":"1989","unstructured":"Homburg R, Eshel A, Armar NA, Tucker M, Mason PW, Adams J, et al. One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. BMJ. 1989;298:809\u201312.","journal-title":"BMJ"},{"key":"2656_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jgyn.2006.12.001","volume":"36","author":"S Christin-Maitre","year":"2007","unstructured":"Christin-Maitre S, de Cr\u00e9cy M. Pregnancy outcomes following pulsatile GnRH treatment: results of a large multicenter retrospective study. J Gynecol Obstet Biol la Reprod. 2007;36:8\u201312.","journal-title":"J Gynecol Obstet Biol la Reprod"},{"key":"2656_CR37","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","volume":"16","author":"JX Wang","year":"2001","unstructured":"Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001;16:2606\u20139.","journal-title":"Hum Reprod"},{"key":"2656_CR38","doi-asserted-by":"crossref","unstructured":"Manfredi-Lozano M, Leysen V, Adamo M, Paiva I, Rovera R, Pignat J-M, et al. GnRH replacement rescues cognition in Down syndrome. Science (80- ). 2022;377.","DOI":"10.1126\/science.abq4515"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02656-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-022-02656-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-022-02656-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T04:16:15Z","timestamp":1672028175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-022-02656-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2656"],"URL":"https:\/\/doi.org\/10.1007\/s10815-022-02656-0","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Swiss Ethics Committees on research involving humans. All the procedures being performed were part of the routine care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMQ and CDG are consultants and\/or speakers for Ferring Pharmaceuticals. Both have no conflicts of interest\/competing interests to declare.AMQ is member of the editorial board of JARG. He has no conflicts of interest\/competing interests to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}